Chronic gastrointestinal inflammation

FEMS Immunology and Medical Microbiology

Volumn 24, Issue 2, 1999, Pages 161-168

  Bamford, Kathleen B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic inflammation; Helicobacter pylori; Inflammatory bowel disease; Mucosal immunity

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM INFLAMMATION; ENTERITIS; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW;

EID: 0032894210     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00021-8     Document Type: Article

References (52)

1. Yakovlev E., Kalichman I., Pisanti S., Shoshan S., Barak V. Levels of cytokines and collagen type I and type III as a function of age in human gingivitis. J. Periodontol. 67:1996;788-793.
2. Asman B., Gustafsson A., Bergstrom K. Gingival crevicular neutrophils: membrane molecules do not distinguish between peridontitis and gingivitis. J. Clin. Periodontol. 24:1997;927-931.
3. Moss S.F., Calam J., Agarwal B., Wang S., Holt P.R. Induction of gastric epithelial cell apoptosis by Helicobacter pylori. Gut. 38:1996;498-501.
4. Fan X.J., Crowe S.E., Bamford K., VanHouten N., Reyes V.E., Ernst P.B. Fas-mediated apoptosis of gastric epithelial cells. Gastroenterology. 112:1997;A968.
5. Fan X.G., Kelleher D., Fan X.J., Xia H.X., Keeling P.W.N. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut. 38:1996;19-22.
6. Ricci V., Ciacci C., Zarrilli R., Sommi P., Tummuru M.K.R., Blanco C.D., Bruni C.B., Cover T.L., Blaser M.J., Romano M. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro - role of vac A and cag A. Infect. Immun. 64:1996;2829-2833.
7. Bechi P., Balzi M., Becciolini A., Maugeri A., Raggi C.C., Amorosi A., Dei R. Helicobacter pylori and cell proliferation of the gastric mucosa: Possible implications for gastric carcinogenesis. Am. J. Gastroenterol. 91:1996;271-276.
8. Gormally S.M., Kierce B.M., Daly L.E., Bourke B., Carroll R., Durnin M.T., Drumm B. Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori. Gut. 38:1996;513-517.
9. Harris A.W., Gummett P.A., Walker M.M., Misiewicz J.J., Baron J.H. Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut. 39:1996;513-520.
10. Atherton J.C., Peek R.M., Tham K.T., Cover T.L., Blaser M.J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 112:1997;92-99.
11. Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341, 1359-1362.
12. Scott N., Lansdown M., Diament R., Rathbone B., Murday V., Wyatt J.I., McMahon M., Dixon M.F., Quirke P. Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet. 335:1990;728.
13. Stevenson E.C., Turner G., Heaney L.G., Schock B.C., Taylor R., Gallagher T., Ennis M., Shields M.D. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin. Exp. Allergy. 27:1997;1027-1035.
14. Neilsen H., Andersen L.P. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leukocytes and monocytes. Gut. 33:1992;738-742.
15. Crabtree J.E., Farmery S.M., Lindley I.J., Figura N., Peichl P., Tompkins D.S. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J. Clin. Pathol. 47:1994;945-950.
16. Atherton J.C., Cao P., Peek R.M., Tummuru M.K., Blaser M.J., Cover T.L. Mosaicism in vacuolating toxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:1995;17771-17777.
17. Xiang Z., Censini S., Bayeli P.F., Telford J.L., Figura N., Rappuoli R., Covacci A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for the expression of the vacuolating toxin. Infect. Immun. 63:1995;94-98.
18. Chmiela M., Czkwianianc E., Wadstrom T., Rudnicka W. Role of Helicobacter pylori surface structures in bacterial interaction with macrophages. Gut. 40:1997;20-24.
19. Faigel D.O., Furth E.E., Childs M., Goin J., Metz D.C. Histological predictors of active Helicobacter pylori infection. Dig. Dis. Sci. 41:1996;937-943.
20. Fung W.P., Papadimitriou J.M., Matz L.R. Endoscopic, histological and ultrastructural correlations in chronic gastritis. Am. J. Gastroenterol. 71:1979;269-279.
21. Crabtree J.E., Shallcross T.M., Heatley R.V., Wyatt J.I. Mucosal tumor necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 32:1991;1473-1477.
22. Reimund J-R., Wittersheim C., Dumont S., Muller C.D., Baumann R., Poindron P., Duclos B.J. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol. 16:1996;144-150.
23. Fan X.J., Chua A., Shahi C.N., McDevitt J., Keeling P.W., Kelleher D. Gastric T lymphocyte responses to Helicobacter pylori in patients with H. pylori colonisation. Gut. 35:1994;1379-1384.
24. Bamford K.B., Fan X.J., Crowe S.E., Leary J.F., Gourley W.K., Luthra G.K., Brooks E.G., Graham D.Y., Reyes V.E., Ernst P.B. CD30- lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 114:1998;482-492.
25. McCallion W.A., Murray L.J., Bailie A.G., Dalzell A.M., O'Reilly D.P., Bamford K.B. Helicobacter pylori infection in children: relation with current household living conditions and area characterisitcs. Gut. 39:1996;18-21.
26. Murray, L.J., Boreham, C., Savage, M. and Bamford, K.B. (1997) H. pylori infection, anthropometry and puberty. Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 41 (Suppl. 1), A65, 07/232.
27. Murray L.J., Bamford K.B., O'Reilly D.P., McCrum E.E., Evans A.E. Helicobacter pylori infection: relation with cardiovascular risk factors ischaemic heart disease and social class. Br. Heart J. 74:1995;497-501.
28. Oppenheim J.J., Zachariae C.O., Mukaida N., Matsushima K. Properties of the novel pro-inflammatory super-gene 'intercrine' cytokine family. Annu. Rev. Immunol. 9:1991;617-648.
29. Lynch D.H., Ramsdell F., Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:1995;569-574.
30. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239-2244.
31. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., Lenardo M.J. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature. 377:1995;348-351.
32. Mondino A., Khoruts A., Jenkins M.K. The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA. 93:1996;2245-2252.
33. Goodnow C.C. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA. 93:1996;2264-2271.
34. Moran A.P., Prendergast M.M., Appelmelk B.J. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:1996;105-115.
35. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA. 93:1996;2260-2263.
36. Schurmann G.M., Bishop A.E., Facer P., Vecchio M., Lee J.C., Rampton D.S., Polak J.M. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 36:1995;411-418.
37. Palmen M.J., Dijkstra C.D., van der Ende M.B., Pena A.S., van Rees E.P. Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin. Exp. Immunol. 101:1995;351-356.
38. Kanoff M.F. Mucosal immunology: new frontiers. Immunol. Today. 17:1996;57-59.
39. Blaser M.J. Hypotheses on the pathogenesis and natural history of Helicobacter pylori induced inflammation. Gastroenterology. 102:1992;720-727.
40. Bamford, K.B., O'Loughlin, B. and Armstrong, M.A. (1996) Variation in the production of TNF-alpha, IL-10, and IL-12 by PBMC and Monomac6 cells exposed to different preparations of Helicobacter pylori. British Society of Immunology- Biochemical Society Joint Congress, Harrogate, December 1996. Immunology 89 (Suppl. 1), CC334.
41. D'Elios M.M., Manghetti M., De Carli M., Costa F., Baldari C.T., Burroni D., Telford J.L., Romagnani S., Del Prete G. T Helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:1997;962-967.
42. Mohommadi M., Czinn S., Redline R., Nedrud J.J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed type hypersensitivity response in the stomachs of mice. J. Immunol. 156:1996;4729-4738.
43. MacDermott R.P. Etiology and pathogenesis of inflammatory bowel disease. Curr. Opin. Gastroenterol. 13:1997;302-306.
44. Neilsen O.H., Raskmadsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 31:(S216):1996;149-159.
45. Berstad A.E., Brandtzaeg P., Stave R., Halstensen T.S. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut. 40:1997;196-203.
46. Berstad A.E., Brandtzaeg P. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut. 42:1998;522-529.
47. Bamford K.B., O'Loughlin B., Tham T.C.K., Collins J.S.A., Sloan J.M., Watson R.G.P. Specific IgG subtype analysis indicates polarisation of the immune response in natural Helicobacter pylori infection. Second European Meeting on Pathogenesis and Host response in Helicobacter pylori infections, Galway, 1997. Irish J. Med. Sci. 166:(Suppl. 3):1997;P20.
48. Schreiber S., Heining T., Theile H-G., Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology. 108:1995;1434-1444.
49. Haeberle H.A., Kubin M., Bamford K.B., Garofalo R., Graham D.Y., El-Zaatari F., Karttunen R., Crowe S.E., Reyes V.E., Ernst P.B. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 with gamma interferon- producing T-cells in the human gastric mucosa. Infect. Immun. 65:1997;4229-4235.
50. Schultz, M. and Sartor, R.B. (1977) Aberrant host responses to lumenal bacteria in the pathogenesis of chronic intestinal inflammation. In: The Immunobiology of H. pylori from Pathogenesis to Prevention (Ernst, P.B.E., Michetti, P. and Smith, P.D., Eds.), Vol. 13, pp. 167-182. Lippincott-Raven, Philadelphia, PA.
51. Duchmann R., Schmitt E., Knolle P., Meyer zum Buschenfelde K.-H., Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26:1996;934-938.
52. Neurath M.F., Fuss I., Kelsall B.L.Stuber,E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1995;1281-1290.